Urologix, Inc. Share Price
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Delayed
OTC Markets
20:48:55 08/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| 01/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.87M 1.76M 1.61M 3M 204M 3.02M 21.09M 8.18M 104M 7.99M 7.82M 337M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.92M 5.56M 5.09M 9.5M 646M 9.58M 66.82M 25.91M 329M 25.32M 24.77M 1.07B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.02 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 31/03/2015 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 15/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 28/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 02/10/2005 |
| Director/Board Member | 59 | 05/08/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | 0.00% | 2.13K | ||
| +0.42% | +3.44% | -35.64% | +26.72% | 3.21B | ||
| +6.91% | +23.42% | +100.43% | +563.41% | 3.28B | ||
| +0.47% | +6.40% | -12.55% | +1,541.34% | 3.05B | ||
| -0.43% | +2.75% | -30.25% | -13.84% | 1.73B | ||
| +6.45% | +16.67% | +168.60% | +579.41% | 1.64B | ||
| 0.00% | +1.56% | -16.24% | +3.34% | 533M | ||
| +0.42% | +3.88% | +20.50% | +43.45% | 359M | ||
| -1.46% | +0.37% | +23.53% | +43.68% | 190M | ||
| 0.00% | +1.59% | +24.27% | +62.03% | 109M | ||
| Average | +1.41% | +4.61% | +24.27% | +284.95% | 1.41B | |
| Weighted average by Cap. | +2.51% | +7.23% | +28.81% | +538.76% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.47M 13.6M 12.43M 23.23M 1.58B 23.41M 163M 63.33M 805M 61.9M 60.55M 2.61B | 14.01M 12.3M 11.56M 10.57M 19.75M 1.34B 19.9M 139M 53.83M 684M 52.62M 51.47M 2.22B |
| Net income | -4.29M -3.77M -3.54M -3.24M -6.05M -411M -6.09M -42.53M -16.49M -210M -16.12M -15.76M -680M | -7.61M -6.68M -6.28M -5.74M -10.72M -729M -10.8M -75.39M -29.23M -372M -28.57M -27.94M -1.2B |
| Net Debt | 3.04M 2.67M 2.51M 2.3M 4.29M 291M 4.32M 30.16M 11.69M 149M 11.43M 11.18M 482M | 4.62M 4.05M 3.81M 3.48M 6.51M 442M 6.55M 45.73M 17.73M 225M 17.33M 16.95M 731M |
Employees
61
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















